CANC Dividend History - Tema Oncology
Track the latest CANC dividend history: 2.83% Dividend Yield, 121.04% Annual Growth - Explore CANC's complete dividend history
Yield 12m
2.83%
Cash Amount 12m
0.73
Dividend Growth 5y avg
121.04%
Dividend Rating
70.85%
Yield on Cost 5y
20.68%
Payout Ratio
-
Payout Frequency 12m
1
Payout Consistency
100.0%
Total Return 12m: -7.87%
#33 in Group
Total Return 5y: 607.35%
#2 in Group
Dividends Cash Amount per Share Yearly
Number of Payouts Yearly
5 Years Chart with Price and Dividend Yield
Top Dividend Payers in Health
Also watched, comparable Dividend Plays
CANC Dividend History - Last 2 Dividends (Paid in USD)
Ex-Date | Record Date | Payment Date | Period | Cash Amount | Growth Rate | Payout Yield |
---|---|---|---|---|---|---|
2024-12-11 | 0.728 | 388.6% | 2.74% | |||
2023-12-13 | 2023-12-14 | 2023-12-15 | Other | 0.149 | 0.6% |
CANC Dividend History - FAQ
Does CANC pay dividends?
Yes, as of March 2025, CANC paid a dividend of 0.73 USD in the last 12 months. The last dividend was paid on 2024-12-11.What is the Dividend Yield of CANC?
As of March 2025, CANC`s dividend yield is 2.83%. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of 730K USD by the current share price of 24.91.How often does CANC pay dividends?
CANC pays dividends annually. Over the last 12 months (TTM), CANC has issued 1 dividend payments.What is the next Ex-Dividend Date for CANC?
The next ex-dividend date for Tema Oncology (CANC) is unknown.What is the Dividend Growth Rate of CANC?
CANC's average dividend growth rate over the past 5 years is 121M% per year.
Strong growth: Dividend growth is outpacing inflation.
What is the Yield on Cost of CANC?
CANC's 5-Year Yield on Cost is 20.7M%. This represents the effective dividend yield for an investor who bought Tema Oncology five years ago. It is calculated as the trailing 12-month dividend cash amount (730K) divided by the purchase price five years ago (3.52):What is the Payout Consistency of CANC?
CANC Payout Consistency is 100.0%.
Highly consistent: Tema Oncology has a strong track record of consistent dividend payments.